Amgen
June 24, 2026
Theater 2
Type: Company Presentation
Focus Area:
Oncology
Amgen is a global biotechnology company focused on discovering, developing, manufacturing, and delivering innovative human therapeutics. Founded in 1980 and headquartered in Thousand Oaks, California, Amgen develops medicines in areas such as oncology, cardiovascular disease, inflammation, bone health, and rare diseases. The company uses advanced genetics and molecular biology to create therapies that address serious illnesses and improve patient outcomes worldwide.
Company HQ City:
Thousand Oaks
Company HQ State:
CA.
Company HQ Country:
United States
Year Founded:
1980
Lead Product in Development:
Maritide
CEO
Bob Bradway
Development Phase of Lead Product
Phase III
Exchange
Nasdaq
Ticker
AMGN
When you expect your next catalyst update?
Late 2026/early 2027
What is your next catalyst (value inflection) update?
Initial Phase III data readouts for MariTide
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}